| MR编号 | DE/H/6834/001 |
|---|
| 药品名称 | Dexmedetomidin Kabi 100 Mikrogramm/ml Konzentrat zur Herstellung einer Infusionslösung |
|---|
| 活性成分 | - Dexmedetomidine hydrochloride 100.0 µg/ml
|
|---|
| 剂型 | Concentrate for solution for infusion |
|---|
| 上市许可持有人 | Fresenius Kabi Deutschland GmbH
Else-Kröner-Str. 1
61352 Bad Homburg
Germany |
|---|
| 参考成员国 - 产品名称 | Germany (DE) Dexmedetomidin Kabi 100 μg/ml Konzentrat zur Herstellung einer Infusionslösung |
|---|
| 互认成员国 - 产品名称 | - Greece (EL)
- Slovak Republic (SK)
Dexmedetomidine Kabi 100 mikrogramov/ml - Sweden (SE)
- Poland (PL)
- Lithuania (LT)
Dexmedetomidine Kabi 100 mikrogramų/ml koncentratas infuziniam tirpalui - Luxembourg (LU)
- United Kingdom (Northern Ireland) (XI)
- Netherlands (NL)
Dexmedetomidine Kabi 100 microgram/ml, concentraat voor oplossing voor infusie - Croatia (HR)
Deksmedetomidin Kabi 100 mikrograma/ml koncentrat za otopinu za infuziju - Finland (FI)
- Belgium (BE)
Dexmedetomidine Kabi 100 microgram/ml concentraat voor oplossing voor infusie - Norway (NO)
Dexmedetomidine Kabi - Denmark (DK)
Dexmedetomidine Kabi - Romania (RO)
Dexmedetomidină Kabi 100 micrograme/ml concentrat pentru soluție perfuzabilă - Italy (IT)
- Czech Republic (CZ)
Dexmedetomidine Kabi - Portugal (PT)
- Cyprus (CY)
Dexmedetomidine/Kabi 100 µg/ml concentrate for solution for infusion - Spain (ES)
- Bulgaria (BG)
Dexmedetomidine Kabi - France (FR)
- Hungary (HU)
Dexmedetomidine Kabi 100 µg/ml koncentrátum oldatos infúzióhoz - Austria (AT)
- Estonia (EE)
DEXMEDETOMIDINE KABI - Ireland (IE)
|
|---|
| 许可日期 | 2021/07/22 |
|---|
| 最近更新日期 | 2025/09/17 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Generic
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|